Lupin rises on getting USFDA approval for its Daysee Tablets

15 Apr 2013 Evaluate

Lupin is currently trading at Rs. 665.50, up by 5.85 points or 0.89% from its previous closing of Rs. 659.65 on the BSE.

The scrip opened at Rs. 654.50 and has touched a high and low of Rs. 668.70 and Rs. 654.50 respectively. So far 6,390 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 668.70 on 15-Apr-2013 and a 52 week low of Rs. 507.00 on 15-Jun-2012.

The current market cap of the company is Rs. 29,774.00 crore.

The promoters holding in the company stood at 46.84%, while Institutions and Non-Institutions held 43.13% and 10.04% respectively.

Lupin’s subsidiary - Lupin Pharmaceuticals Inc. (collectively Lupin) has received final approval for its Daysee Tablets (Levonorgestrel and Ethinyl Estradiol Tablets, USP, 0.15 mg/0.03 mg and Ethinyl Estradiol Tablets, USP, 0.01 mg) from the United States Food and Drugs Administration (US FDA) to market a generic version of Teva Branded Pharm.’s Seasonique Tablets.

Lupin’s Daysee Tablets is indicated for use by women to prevent pregnancy. The total sales for Branded and generic sales for the product stood at $161 million (IMS MAT Dec 2012). Lupin has already commenced shipping the product.

Lupin is the 5th largest and fastest growing generics player in the US (5.1% market share by prescriptions, IMS Health) and the 3rd largest Indian pharmaceutical company by sales. The company is also the fastest growing top 10 generic pharmaceutical players in Japan and South Africa (IMS).

Lupin Share Price

2071.35 -26.30 (-1.25%)
08-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1795.30
Dr. Reddys Lab 1267.15
Cipla 1497.45
Zydus Lifesciences 924.35
Lupin 2071.35
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×